WI
BIIB icon

Wafra Inc’s Biogen BIIB Stock Holding History

Wafra Inc’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-44,430
Closed -$10.5M – 80
2019
Q1 		$10.5M Sell
44,430
-37,745
-46% -$11.9M 0.37% 44
2018
Q4 		$24.7M Buy
82,175
+34,724
+73% +$11.1M 0.97% 11
2018
Q3 		$16.8M Buy
+47,451
New +$16.3M 0.57% 30
2016
Q1 		– Sell
-3,550
Closed -$1.09M – 90
2015
Q4 		$1.09M Hold
3,550
– – 0.13% 66
2015
Q3 		$1.04M Buy
+3,550
New +$1.17M 0.13% 60
2014
Q2 		– Sell
-52,400
Closed -$16M – 69
2014
Q1 		$16M Buy
52,400
+8,300
+19% +$2.63M 1.94% 17
2013
Q4 		$12.3M Buy
+44,100
New +$11.4M 1.58% 23

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wafra Inc's BIIB Position: Q2 2019 in Review

Wafra Inc sold out of Biogen (BIIB) in Q2 2019, closing a stake of 44,430 shares — an estimated $10.5M sold.

Wafra Inc first reported a position in BIIB in Q4 2013 and held it in 7 quarters. The position peaked at $24.7M in Q4 2018. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Wafra Inc reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Wafra Inc sold 44,430 Biogen shares in Q2 2019, an estimated $10.5M.
  • Wafra Inc first reported a position in Biogen in Q4 2013 and held it in 7 quarters.
  • Wafra Inc's Biogen position peaked at $24.7M in Q4 2018.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Wafra Inc's 13F filing for Q2 2019, filed 14 Aug 2019.